Journey Medical Corp. (DERM)
8.13
-0.07
(-0.85%)
USD |
NASDAQ |
Dec 09, 16:00
8.11
-0.02
(-0.25%)
Pre-Market: 20:00
Journey Medical EPS Diluted (Quarterly): -0.0928 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fortress Biotech, Inc. | 0.111 |
| electroCore, Inc. | -0.4032 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.315M |
| Revenue (Quarterly) | 17.63M |
| Total Expenses (Quarterly) | 19.95M |
| Enterprise Value | 220.97M |
| Gross Profit Margin (Quarterly) | 61.32% |
| Profit Margin (Quarterly) | -13.13% |
| Earnings Yield | -4.52% |
| Normalized Earnings Yield | -4.517 |